Viewing StudyNCT00121836



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00121836
Status: COMPLETED
Last Update Posted: 2011-04-27
First Post: 2005-07-18

Brief Title: A Study of Xeloda Capecitabine in Women With HER2-Negative Metastatic Breast Cancer
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords: